These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1881688)

  • 21. High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids.
    Koechlin C; Jehl F; Linger L; Monteil H
    J Chromatogr; 1989 Jul; 491(2):379-87. PubMed ID: 2509509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new tricyclic fluoroquinolone, rufloxacin (MF-934), with interesting antibacterial and pharmacokinetic characteristics.
    Segre G; Cerretani D; Cerri D; Moltoni L
    Drugs Exp Clin Res; 1988; 14(12):747-54. PubMed ID: 3253051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.
    Nakagawa T; Ishigai M; Hiramatsu Y; Kinoshita H; Ishitani Y; Ohkubo K; Okazaki A
    Arzneimittelforschung; 1995 Jun; 45(6):716-8. PubMed ID: 7646578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rufloxacin, a new fluoroquinolone in biological fluids by high-performance liquid chromatography.
    Carlucci G; Fanini D; Pantaleoni GC; Palumbo G
    Acta Physiol Hung; 1990; 75 Suppl():49-50. PubMed ID: 2371900
    [No Abstract]   [Full Text] [Related]  

  • 28. Biliary elimination of apalcillin: an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Dorner M; Lautier F
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):180-7. PubMed ID: 3710630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of ciprofloxacin in the isolated perfused rat liver.
    Abadìa AR; De Francesco L; Guaitani A
    Drug Metab Dispos; 1995 Feb; 23(2):197-200. PubMed ID: 7736911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic clearance of gitoxin. Metabolism and biliary excretion by rabbit isolated liver.
    Pellegrin PL; Lesne M
    Drug Metab Dispos; 1984; 12(2):235-41. PubMed ID: 6144490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():55-64. PubMed ID: 1664830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
    Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
    Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between disc potency and zone size in temafloxacin activity in vitro.
    Reggio S; Bassanetti I; Ceralli M; Giardini R; Sansonetti G
    Drugs Exp Clin Res; 1990; 16(12):611-4. PubMed ID: 2130003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat.
    Sasabe H; Terasaki T; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Jul; 282(1):162-71. PubMed ID: 9223551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats.
    Catapano CV; Guaitani A; Broggini M; Corada M; Bartosek I; Italia C; Donelli MG
    Anticancer Res; 1988; 8(4):725-31. PubMed ID: 3178163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
    Granneman GR; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():48-56. PubMed ID: 1319871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
    Dalvie DK; Khosla NB; Navetta KA; Brighty KE
    Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.